|
Status |
Public on Sep 16, 2017 |
Title |
AmpliSeq analysis of human iPSC-derived cardiomyocytes |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Analysis of human iPSC-derived cardiomyocytes unstimulated or stimulated with endothelin-1 in the presence of either vehicle (DMSO), Ivermectin, Importazole, IPA-3, or verapamil. Results provide insight into the pathways regulated by the treatments.
|
|
|
Overall design |
AmpliSeq of human iPSC-derived cardiomyocytes untreated or treated with endothelin-1 in the presence of either vehicle (DMSO), Ivermectin, Importazole, IPA-3, or verapamil for 18 hours, in quadruplicate, using Ion Proton System.
|
|
|
Contributor(s) |
Satomi T, Nagai H, Kikuchi K, Tozaki H |
Citation(s) |
28942281 |
|
Submission date |
Mar 23, 2017 |
Last update date |
May 15, 2019 |
Contact name |
Yoshiyuki Tsujihata |
E-mail(s) |
yoshiyuki.tsujihata@takeda.com
|
Phone |
+81-466-32-1788
|
Organization name |
Takeda Pharmaceutical Company Limited
|
Street address |
26-1, Muraoka-Higashi 2-chome
|
City |
Fujisawa |
State/province |
Kanagawa |
ZIP/Postal code |
2518555 |
Country |
Japan |
|
|
Platforms (1) |
GPL17303 |
Ion Torrent Proton (Homo sapiens) |
|
Samples (24)
|
|
This SubSeries is part of SuperSeries: |
GSE96989 |
RNA sequencing analysis of cardiomyocytes |
|
Relations |
BioProject |
PRJNA380271 |
SRA |
SRP102430 |